Pancreatic Cancer Clinical Trials

Northwest Alabama Cancer Center
Muscle Shoals Alabama 35661

A clinical trial to evaluate treatments using Kanglaite Injection plus gemcitabine and Gemcitabine for patients with Pancreatic Cancer

Scottsdale Arizona 85258

Patients are needed to participate in a clinical research study evaluating BIND-014 for the treatment of Metastatic Cancer, Cancer or Solid Tumors

Scottsdale Arizona

Patients are needed to participate in a clinical research study evaluating Ferumoxytol followed by MM-398

Mayo Clinic Arizona
Scottsdale Arizona 85259

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Disney Family Cancer Center
Burbank California 91505

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Greenbrae California 94904

Patients are needed to participate in a clinical research study evaluating BIND-014 for the treatment of Metastatic Cancer, Cancer or Solid Tumors

Scripps Clinic Torrey Pines ( Green Hospital)
La Jolla California 92037

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Cedars-Sinai Medical Center
Los Angeles California 90048

A clinical trial to evaluate treatments using Veliparib, Gemcitabine and Intensity modulated radiation therapy for patients with Pancreatic Cancer

University of Southern California, Norris Comprehensive Cancer Center
Los Angeles California 90033

A Phase 1 clinical study for patients with Advanced Solid Tumors

University of Colorado Denver
Aurora Colorado 80045

Gemcitabine/Capecitabine/ZD6474 in Advanced Solid Tumors

Stamford Hospital
Stamford Connecticut 06902
Updated

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Helen F. Graham Cancer Center
Newark Delaware 19713

Patients are needed to participate in a clinical research study of IMMU-132

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Washington District of Columbia

Patients are needed to participate in a clinical research study evaluating LY2495655 and Placebo for the treatment of Pancreatic Cancer

Boca Raton Regional Hospital
Boca Raton Florida 33486
Updated

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Broward Oncology Associates
Fort Lauderdale Florida 33308

A clinical trial to evaluate treatments using Kanglaite Injection plus gemcitabine and Gemcitabine for patients with Pancreatic Cancer

Fort Myers Florida 33905

Patients are needed to participate in a clinical research study evaluating BIND-014 for the treatment of Metastatic Cancer, Cancer or Solid Tumors

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Jacksonville Florida 32224

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

University of Miami
Miami Florida 33136
Updated

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

Medical and Surgical Specialists
Galesburg Illinois 61401

A clinical trial to evaluate treatments using Kanglaite Injection plus gemcitabine and Gemcitabine for patients with Pancreatic Cancer

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Harvey Illinois 60426

A clinical trial to evaluate treatments using LY2157299, Gemcitabine and Placebo for patients with Neoplasms, Neoplasm Metastasis or Pancreatic Cancer

Loyola University Medical Center/Cardinal Bernardin Cancer Center
Maywood Illinois 60153

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Hematology / Oncology of the North Shore
Skokie Illinois 60076

A clinical trial to evaluate treatments using Kanglaite Injection plus gemcitabine and Gemcitabine for patients with Pancreatic Cancer

IU Health Goshen Cancer Center
Goshen Indiana 46526

Patients are needed to participate in a clinical research study of IMMU-132

Indiana University Health, Goshen Center for Cancer Care
Goshen Indiana 46526

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Holden Comprehensive Cancer Center
Iowa City Iowa 52242

A Phase 1 clinical study for patients with Pancreatic Neoplasms

Mary Bird Perkins Cancer Center
Baton Rouge Louisiana 70509

A clinical trial to evaluate treatments using Kanglaite Injection plus gemcitabine and Gemcitabine for patients with Pancreatic Cancer

Fesit-Weiller Cancer Center
Shreveport Louisiana 71130

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Johns Hopkins Kimmel Comprehensive Cancer Center
Baltimore Maryland 21231

A clinical trial seeking patients for a research study for the treatment of Metastatic Pancreatic Cancer or Metastatic Colorectal Cancer

Johns Hopkins Hospital
Baltimore Maryland 21287

A Phase 3 clinical study for patients with Pancreatic Solid Lesions or Pancreatic Mass

National Cancer Institute
Bethesda Maryland 20892

A clinical trial seeking patients for a research study for the treatment of Metastatic, Locally Advanced Unresectable or Recurrent Pancreatic Cancer.

NCI, CCR
Bethesda Maryland 20892

Patients are needed to participate in a clinical research study of GI-6301 to evaluate Solid Tumors

Massachusetts General Hospital Dept. of Mass General Hospital
Boston Massachusetts 02114

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

Massachusetts General Hospital Cancer Center
Boston Massachusetts 02114

A clinical trial to evaluate treatments using MGA271 for patients

Dana Farber Cancer Institute
Boston Massachusetts 02215

A clinical trial to evaluate treatments using MGA271 for patients

Detroit Michigan 48201

Patients are needed to participate in a clinical research study evaluating BIND-014 for the treatment of Metastatic Cancer, Cancer or Solid Tumors

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Detroit Michigan

Patients are needed to participate in a clinical research study evaluating LY2495655 and Placebo for the treatment of Pancreatic Cancer

Karmanos Cancer Institute
Detroit Michigan 48201

Patients are needed to participate in a clinical research study of Cryoablation using Galil Medical systems and needles to evaluate Pain or Pancreatic Cancer

Saint Mary's Health Care
Grand Rapids Michigan 49503

Patients are needed to participate in a clinical research study to evaluate Metastatic Pancreatic Cancer

Virginia Piper Cancer Institute
Minneapolis Minnesota 55407-3799
Updated

Patients are needed to participate in a clinical research study of FOLFIRINOX, HyperAcute®-Pancreas Immunotherapy, 5-FU Chemoradiation and Gemcitabine to evaluate Pancreatic Cancer, Pancreatic Carcinoma Non-resectable or Locally Advanced Malignant Neoplasm

For additional information regarding investigative sites for this trial, contact 1-877-CTLILLY (1-877-285-4559, 1-317-615-4559) Mon - Fri from 9 AM to 5 PM Eastern Time (UTC/GMT - 5 hours, EST), or speak with your personal physician.
Rochester Minnesota 55905

A clinical trial seeking patients for a research study for the treatment of Pancreatic Cancer

Research Medical Center
Kansas City Missouri 64132

A clinical trial to evaluate treatments using Kanglaite Injection plus gemcitabine and Gemcitabine for patients with Pancreatic Cancer